Clinical Trial Update: Oral Vinorelbine as Induction Chemotherapy Followed Concomitant Chemoradiotherapy [Phase 2]

View source ↗

Summary

This Phase 2 trial investigates oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy in lung cancer. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Navelbine (vinorelbine)

Snippet

Sponsor: Pierre Fabre Medicament | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED